The largest insider transaction on today’s list comes in a Form 4 filing from Steven J. McLaughlin of fintech-focused investment banking firm FT Partners.
McLaughlin revealed a purchase of $2.9 million in Expensify Inc $EXFY.
The largest insider transaction on today’s list comes in a Form 4 filing from the CEO and chief business and strategic operations officer of Cerevel Therapeutics Holdings $CERE.
The two executives reported purchases for a combined amount of $2.5 million.
Welcome back to Under the Hood, where we'll cover all the action for the week ended August 4, 2023. This report is published bi-weekly and rotated with The Minor Leaguers.
What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.
We use a variety of sources to generate the list of most popular names.
There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.
From the Desk of Steve Strazza @sstrazza and Alfonso Depablos @Alfcharts
This is one of our favorite bottom-up scans: Follow the Flow.
In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.
We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.
Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.
The largest insider transaction on today’s list comes in a Form 4 filing by Karin Rotem-Wildeman, Chief Research & Development Officer for Keurig Dr Pepper $KDP.
Rotem-Wildeman reported a purchase of KDP shares worth roughly $1.8 million.